OKUR · NASDAQ · Biotechnology

OnKure Therapeutics (OKUR)

Develops mutation-selective PI3Kα medicines for cancer and vascular anomalies.

$2.95
vs last close−0.16 (−5.00%)

Something off on this page? Send us feedback.

Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$0.36
Revenue estimate
$166.7K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.37−$1.19−$1.14−$1.09−$0.99−$1.11−$0.31Pending
Estimate−$0.86−$1.32−$1.23−$1.20−$1.15−$0.81−$0.54−$0.36
Surprise−59.3%+9.8%+7.3%+9.2%+13.9%−37.0%+42.1%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
ReportedPending
Estimate$16.0M$166.7K$166.7K$166.7K
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2027−$0.25
Sep 2027−$0.28
Jun 2027−$0.32
Mar 2027−$0.31
Dec 2026−$0.44
Nov 2026−$0.36
Aug 2026−$0.54−$0.31+42.1%
May 2026−$0.81−$1.11−37.0%
Mar 2026−$1.15−$0.99+13.9%
Nov 2025−$1.20−$1.09+9.2%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022

The latest year is open to everyone — the 12 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2027−$0.25$500.0K
Sep 2027−$0.28$500.0K
Jun 2027−$0.32$500.0K
Mar 2027−$0.31$500.0K
Dec 2026−$0.44$166.7K
Nov 5, 2026−$0.36$166.7K
Aug 4, 2026−$0.54−$0.31+42.1%$166.7K+1.5%
May 5, 2026−$0.81−$1.11−37.0%$166.7K−1.7%
Mar 12, 2026−$1.15−$0.99+13.9%$16.0M−0.3%
Nov 6, 2025−$1.20−$1.09+9.2%+5.3%
Aug 12, 2025
May 6, 2025
Mar 10, 2025
Nov 7, 2024
Aug 13, 2024
May 7, 2024
Mar 28, 2024
Nov 13, 2023
Aug 10, 2023
May 11, 2023
Mar 27, 2023
Nov 8, 2022

The latest year is open to everyone — the 12 quarters behind it read with an account.